Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Scand J Rheumatol ; 50(3): 231-238, 2021 May.
Artigo em Inglês | MEDLINE | ID: mdl-33243053

RESUMO

Objective: To investigate the relationship between the monocyte-to-high-density lipoprotein cholesterol ratio (MHR) and clinical manifestations in patients with systemic sclerosis (SSc).Method: This was a cross-sectional analysis of a cohort study comprising 111 female SSc patients recruited from a tertiary care rheumatology centre. We also assessed 222 age-matched female healthy controls. Serum MHR was measured in all study participants. Digital ulcer (DU) was defined as an active or healed ulceration, and the magnitude of skin fibrosis was determined according to the modified Rodnan skin score (mRSS).Results: The mean age and median disease duration in patients with SSc were 56.3 years and 98 months, respectively. The MHR in SSc patients was significantly higher than that in controls. DU was found in 35 patients (31.5%) with SSc (active in 12 and healed in 23), and the median mRSS was 8. SSc patients with DU had a significantly higher median MHR than those without (11.43 vs 7.62, p < 0.001), and MHR significantly positively correlated with mRSS (ρ = 0.289, p = 0.002). Multivariable logistic regression revealed that an elevated MHR was independently associated with increased risk of DU (odds ratio = 1.21; 95% confidence interval = 1.07-1.35; p = 0.002). In the multivariable linear regression analysis, higher MHR showed a significant association with increased log-transformed mRSS (unstandardized ß = 0.052, p = 0.003).Conclusion: Our findings suggest that the MHR could be serve as a potential biomarker of the risk of DU and advanced skin fibrosis in patients with SSc.


Assuntos
HDL-Colesterol/sangue , Fibrose/sangue , Monócitos/metabolismo , Escleroderma Sistêmico/sangue , Úlcera Cutânea/sangue , Pele/patologia , Biomarcadores/sangue , Estudos Transversais , Feminino , Fibrose/patologia , Humanos , Pessoa de Meia-Idade , Escleroderma Sistêmico/patologia , Úlcera Cutânea/patologia
2.
Scand J Rheumatol ; 40(6): 444-7, 2011 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-21916803

RESUMO

OBJECTIVE: To identify factors associated with acute gout attacks in normouricaemic gout patients receiving allopurinol. METHODS: We reviewed the medical records of 860 patients with chronic gout who were treated with allopurinol at a single tertiary hospital between 2003 and 2009. Of these, 135 patients had serum urate concentrations ≤ 360 µmol/L (6 mg/dL). Patients whose serum urate concentrations exceeded 360 µmol/L (6 mg/dL) at least once during follow-up were excluded. Patients who experienced at least one acute attack during follow-up, despite normouricaemia [≤ 360 µmol/L (6 mg/dL)], were classified as the Attack group (n = 51). The others were classified as the Non-attack group (n = 84). RESULTS: The gout disease duration was significantly longer in the Attack group than in the Non-attack group (p = 0.036). The presence of tophi and multiple joint involvement were associated with acute attacks in normouricaemic gout patients. Multivariate analysis showed that both the presence of tophi [odds ratio (OR) 4.16, 95% confidence interval (CI) 1.41-12.23, p = 0.010] and the number of involved joints (OR 1.51, 95% CI 1.05-2.17, p = 0.028) were independently associated with acute attacks in normouricaemic gout patients receiving allopurinol. CONCLUSION: The presence of tophi and multiple joint involvement were associated with acute attacks in normouricaemic gout patients receiving allopurinol.


Assuntos
Alopurinol/administração & dosagem , Supressores da Gota/administração & dosagem , Gota/etiologia , Doença Aguda , Idoso , Artrite Gotosa/complicações , Gota/diagnóstico , Gota/tratamento farmacológico , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Fatores de Risco , Ácido Úrico/sangue
3.
J Bacteriol ; 182(1): 143-5, 2000 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-10613873

RESUMO

The pathway of cysteine biosynthesis in archaea is still unexplored. Complementation of a cysteine auxotrophic Escherichia coli strain NK3 led to the isolation of the Methanosarcina barkeri cysK gene [encoding O-acetylserine (thiol)-lyase-A], which displays great similarity to bacterial cysK genes. Adjacent to cysK is an open reading frame orthologous to bacterial cysE (serine transacetylase) genes. These two genes could account for cysteine biosynthesis in this archaeon. Analysis of recent genome data revealed the presence of bacteria-like cysM genes [encoding O-acetylserine (thiol)-lyase-B] in Pyrococcus spp., Sulfolobus solfataricus, and Thermoplasma acidophilum. However, no orthologs for these genes can be found in Methanococcus jannaschii, Methanobacterium thermoautotrophicum, and Archaeoglobus fulgidus, implying the existence of unrecognizable genes for the same function or a different cysteine biosynthesis pathway.


Assuntos
Acetiltransferases , Proteínas Arqueais/genética , Proteínas de Bactérias/genética , Cisteína Sintase/genética , Cisteína/biossíntese , Methanosarcina/metabolismo , Proteínas Arqueais/metabolismo , Proteínas de Bactérias/metabolismo , Cisteína Sintase/metabolismo , Escherichia coli/genética , Proteínas de Escherichia coli , Teste de Complementação Genética , Methanosarcina/genética , Dados de Sequência Molecular , Filogenia , Serina O-Acetiltransferase
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA